Independent meta-analyses by Melanoma Institute of Australia on CP-GEP model in Melanoma Care [Yahoo! Finance]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Yahoo! Finance
development of molecular diagnostics for oncology, inflammatory, and infectious diseases, announced today the results of a comprehensive systematic review and meta-analysis conducted by Melanoma Institute of Australia (MIA). This independent study validates the predictive power of SkylineDx's Clinicopathologic Gene Expression Profile ( CP-GEP ) model, known as the Merlin test, in guiding the decision-making process for Sentinel Lymph Node Biopsy ( SLNB ) in patients with cutaneous melanoma [1]. SLNB is a standard, yet invasive, procedure used to accurately stage melanoma and guide further treatment. Recommended for patients with melanomas that exceed a Breslow thickness of 1.0 mm, SLNB is crucial in detecting the spread of cancer to the lymph nodes. However, with a relatively low positive detection rate—only 15% to 20% of patients undergoing SLNB have nodal metastasis—many patients undergo the surgery unnecessarily. The Merlin CP-GEP model addresses this issue by identifying patient
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- $6.1 Bn Dietary Supplement Testing Services Global Market Opportunities and Strategies to 2033: Contaminant Testing Platforms, Adulteration Panel Analysis, AI-Driven Platforms for Improved Testing [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]Yahoo! Finance
- Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson's Disease [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics Incorporated (NYSE: DGX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Vitamin D Testing Market Size to Reach USD 1774.70 Million by 2031 | SkyQuest Technology [Yahoo! Finance]Yahoo! Finance
DGX
Earnings
- 10/22/24 - Beat
DGX
Sec Filings
- 11/7/24 - Form 4
- 10/30/24 - Form 4
- 10/28/24 - Form 144
- DGX's page on the SEC website